The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Induction of Tumor Immunity by Photodynamic Therapy
Abstract
The mechanism of tumor destruction by photodynamic therapy (PDT) incorporates a variety of events leading to inactivation of tumor cells. The unique feature of PDT is the mobilization of the host to participate in the eradication of treated cancer. A critical element is the induced inflammation at the treated site associated with massive invasion of activated myeloid cells. In addition to further destruction of cancer cells, conditions are created for the presentation of tumor antigens with subsequent activation of lymphoid cells, leading to tumor-specific immunity. This inflammation-primed immune development process results in generation of tumor-specific immune memory cells that appear to be elicited against both strongly and poorly immunogenic PDT-treated cancers. Once generated by PDT, it is conceivable that these immune cells (especially if further expanded and activated by adjuvant immunotherapy) can be engaged in additional eradication of disseminated and/or metastatic lesions of the same cancer. A number of immunotherapy regimens have already been proven effective in enhancing the curative effect of PDT with various animal tumor models. Inflamed cancerous tissue at the PDT-treated site appears to exert powerful attracting signals for immune cells activated by different immunotherapy regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HOW DOES PHOTODYNAMIC THERAPY WORK?
Henderson, B. W., & Dougherty, T. J. (1992) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1992.tb04222.x · Cited by 2,358
Photodynamic Therapy in Oncology: Mechanisms and Clinical Use
Pass, H. I. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.6.443 · Cited by 751
Role of neutrophils in ischemia-reperfusion-induced microvascular injury
Hernandez, L. A., Grisham, M. B., Twohig, B., Arfors, K. E., Harlan, J. M., & Granger, D. N. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.253.3.h699 · Cited by 698
Metzger, Z., Hoffeld, J. T., & Oppenheim, J. J. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.2.983 · Cited by 339
Freedman, A. S., Freeman, G. J., Rhynhart, K., & Nadler, L. M. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90091-o · Cited by 312
Experimental and Clinical Studies of Cytokine Gene-Modified Tumor Cells
Tepper, R. I., & Mulé, J. J. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.2-153 · Cited by 254
Krosl, G., Korbelik, M., & Dougherty, G. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.108 · Cited by 219
Self-citationPhospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells.
Agarwal, M. L., Larkin, H. E., Zaidi, S. I. A., Mukhtar, H., & Oleinick, N. L. (1993) · PubMed · Cited by 203
The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
Korbelik, M., Krosl, G., Krošl, J., & Dougherty, G. J. (1996) · PubMed · Cited by 165
Self-citationCantl, G., Lattuada, D., Nicolin, A., Taroni, P., Valentinl, G., & Cubeddu, R. (1994) · Anti-Cancer Drugs · doi:10.1097/00001813-199408000-00009 · Cited by 110
Cited by
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., & Peng, Q. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.889 · Cited by 4,716
Self-citationPhotodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
Basic principles of photodynamic therapy
MACDONALD, I. J., & DOUGHERTY, T. J. (2001) · Journal of Porphyrins and Phthalocyanines · doi:10.1002/jpp.328 · Cited by 1,396
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Bioinorganic Photochemistry: Frontiers and Mechanisms
Szaciłowski, K., Macyk, W., Drzewiecka-Matuszek, A., Brindell, M., & Stochel, G. (2005) · Chemical Reviews · doi:10.1021/cr030707e · Cited by 725
The History of Photodetection and Photodynamic Therapy¶
Ackroyd, R., Kelty, C., Brown, N., & Reed, M. (2007) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2001)0740656thopap2.0.co2 · Cited by 667
Photodynamic Therapy—Current Limitations and Novel Approaches
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.691697 · Cited by 599
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Alzeibak, R., Mishchenko, T. A., Shilyagina, N. Y., Balalaeva, I. V., Vedunova, M. V., & Krysko, D. V. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001926 · Cited by 565
Castano, A. P., Demidova, T. N., & Hamblin, M. R. (2005) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00060-8 · Cited by 552
Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy
Ji, B., Wei, M., & Yang, B. (2022) · Theranostics · doi:10.7150/thno.67300 · Cited by 544
Photodynamic therapy in dermatology
Kalka, K., Merk, H., & Mukhtar, H. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90209-3 · Cited by 522
Role of cytokines in photodynamic therapy-induced local and systemic inflammation
Gollnick, S. O., Evans, S. S., Baumann, H., Owczarczak, B., Maier, P., Vaughan, L., Wang, W. C., Unger, E., & Henderson, B. W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600864 · Cited by 348
Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges
Huang, Z., Xu, H., Meyers, A. D., Musani, A. I., Wang, L., Tagg, R., Barqawi, A. B., & Chen, Y. K. (2008) · Technology in Cancer Research & Treatment · doi:10.1177/153303460800700405 · Cited by 337
Upconversion-based photodynamic cancer therapy
Liu, Y., Meng, X., & Bu, W. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.09.006 · Cited by 319
Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial
Wang, I., Bendsoe, N., Klinteberg, C. A., Enejder, A. M. K., Andersson-Engels, S., Svanberg, S., & Svanberg, K. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04141.x · Cited by 309
Milestones in the development of photodynamic therapy and fluorescence diagnosis
Juzeniene, A., Peng, Q., & Moan, J. (2007) · Photochemical & Photobiological Sciences · doi:10.1039/b705461k · Cited by 273
Henderson, B. W., Gollnick, S. O., Snyder, J. W., Busch, T. M., Kousis, P. C., Cheney, R. T., & Morgan, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3513 · Cited by 263
Stimulation of anti-tumor immunity by photodynamic therapy
Mroz, P., Hashmi, J. T., Huang, Y.-Y., Lange, N., & Hamblin, M. R. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.81 · Cited by 261
5‐ALA in the management of malignant glioma
Stepp, H., & Stummer, W. (2018) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22933 · Cited by 234
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
Castano, A. P., Mroz, P., Wu, M. X., & Hamblin, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709256105 · Cited by 201
“Mechanisms that have been shown to be involved in the tumoricidal effect include direct cytotoxicity to tumor cells (13), shutting down of the tumor vasculature, thus starving the tumor of oxygen or nutrients (14), and the induction of a host immune response (15).”
BackgroundAdamek, M., Kawczyk-Krupka, A., Mostowy, A., Czuba, Z., Krol, W., Kasperczyk, S., Jakobisiak, M., Golab, J., & Sieron, A. (2005) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00004-9 · Cited by 19
Metadata
- Authors
- KORBELIK, M.
- Venue
- Journal of Clinical Laser Medicine & Surgery
- Publisher
- SAGE Publications
- Published
- 1996-10
- Volume
- 14
- Issue
- 5
- Pages
- 329-334
- ISSN
- 1044-5471 (ISSN-L)
- 1557-8089
- OpenAlex
- W60206895
- Cited by
- 256
- References
- 23
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.